# Progress Note 06 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Natsume Sōseki (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET023-SYN-TD
- Date: 1910-08-03
- Fictional facility: St. Posthumous Health Center
- Fictional author: Haruka Lindqvist-Mori, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Eleven-week review: urea breath test, repeat endoscopy, anemia, and surveillance. **S**

## History of present illness

Mr. Natsume returns eleven weeks after diagnosis. He completed the 14 days of vonoprazan-amoxicillin dual therapy, missing no doses, with loose stools that settled after the course. He took vonoprazan each morning for the full eight weeks and stopped it two and a half weeks ago; he has had no epigastric pain since. He has had no tarry stools, vomiting or fainting. His back pain settled within two weeks. He takes iron every other morning and feels much less tired. He fasted this morning for the urea breath test and the repeat endoscopy with Dr. Abrahamsen-Ito. **S**

| Element | Detail |
|---|---|
| Eradication | 14-day course completed seven weeks ago |
| Vonoprazan | Eight weeks completed; stopped two and a half weeks ago |
| Symptoms | No pain, bleeding or tiredness |
| Testing today | 13C urea breath test, then repeat endoscopy with scar biopsies; blood count and ferritin |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy good; weight up |
| Gastrointestinal | Negative | No epigastric pain, heartburn, vomiting or tarry stools |
| Musculoskeletal | Negative | Back pain gone |
| Psychiatric | Negative | Mood good; PHQ-9 3 |

4 systems reviewed. **S**

## Current medications

- Acetaminophen 500 mg oral tablet, one or two tablets by mouth every six hours as needed for headache or pain, no more than 3 g a day (in place of ibuprofen) **S**
- Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other day **S**

## Allergies

- No known allergy **S**

## Objective

BP 118/74 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 53.6 kg; BMI 21.2 kg/m². All vital signs are synthetic.

Hemoglobin: 14 g/dL; MCV: 85 fL; Ferritin: 46 ng/mL; PHQ-9: 3; GAD-7: 4. All results are synthetic.

## Change since baseline

- Hemoglobin: 11.2 g/dL (low) at baseline, 14 g/dL at this visit **S**
- MCV: 76 fL (low) at baseline, 85 fL at this visit **S**
- Ferritin: 8 ng/mL (low) at baseline, 46 ng/mL at this visit **S**
- PHQ-9: 7 at baseline, 3 at this visit **S**
- GAD-7: 8 at baseline, 4 at this visit **S**

## Immunizations given today

- Hepatitis B vaccine (HepB-CpG), dose 2 of 2 **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; weight 53.6 kg, BMI 21.2; pulse 72, blood pressure 118/74 |
| Conjunctivae | Pink |
| Abdomen | Soft and non-tender |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Helicobacter pylori eradicated** (B96.81). The 13C urea breath test, done seven weeks after the antibiotics and more than two weeks after stopping vonoprazan, is negative: eradication confirmed. **S**
   - No further treatment.
2. **Gastric ulcer, healed** (K25.4). Repeat endoscopy shows the ulcer healed to a white scar with no residual ulcer; scar biopsies were taken. With the ulcer healed, H. pylori eradicated and no NSAIDs, he does not need long-term acid suppression. **S**
   - Scar biopsy result by phone.
   - No NSAIDs, now or later.
3. **Chronic atrophic gastritis with intestinal metaplasia** (K29.40). Open-type atrophy unchanged at endoscopy; no new lesion. **S**
   - Upper endoscopy yearly, starting one year from now.
4. **Iron-deficiency anemia, corrected** (D50.0). Hemoglobin 14.0 g/dL and MCV 85 fL: corrected; ferritin 46 ng/mL, not yet 50. With the anemia corrected after the ulcer healed, colonoscopy is not needed now; screening begins at 45. **S**
   - Continue iron every other morning for three more months.
   - Blood count and ferritin in three months.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | Test of eradication (13C urea breath test) | At least four weeks after antibiotics and two weeks after acid suppression | Completed today | Negative seven weeks after the antibiotics and two and a half weeks off vonoprazan: eradicated |
| Imaging | Upper endoscopy with biopsy of the ulcer margin | At diagnosis; repeat for a gastric ulcer at 8 to 12 weeks to confirm healing and biopsy the scar | Completed today | Healed to a white scar; scar biopsies sent |
| Medication safety | Eradication therapy: adherence and side effects | At the start and during the course | Completed today | Course completed without missed doses; loose stools settled |
| Medication safety | Acid suppression for ulcer healing (vonoprazan) | Daily for eight weeks for a gastric ulcer | Completed today | Eight weeks completed; stopped; no long-term acid suppression needed |
| Medication safety | NSAID avoidance | Every visit | Completed today | None since the first visit, including during the back strain |
| Self-management | Bleeding warning signs and when to call 119 | Every visit | Completed today | No bleeding; warning signs reviewed for the future |
| Laboratory | Blood count on oral iron | About four weeks after starting oral iron, then every three months for a year (CMID) | Deferred | Missed: the blood count due about four weeks after starting iron was not done because no laboratory visit was booked. No harm judging by today's hemoglobin of 14.0 g/dL and MCV of 85 fL. Corrective action: the three-month count is booked as a laboratory visit with a reminder |
| Laboratory | Ferritin | At the end of the iron course; target 30 ng/mL or more, ideally 50 (CMID) | Completed today | 46 ng/mL: replete, below the ideal of 50; iron continues three months |
| Examination | Colonoscopy for iron-deficiency anemia | For iron-deficiency anemia in an adult man, unless an upper source explains it and the anemia corrects (CMID) | Not indicated | The ulcer explained the bleeding and the anemia has corrected; colorectal screening from 45 |
| Laboratory | Gastric cancer surveillance: atrophy and intestinal metaplasia staging | Endoscopy yearly after eradication when atrophy or intestinal metaplasia is present | Due | Next endoscopy in one year |
| Survey | Stress and depression: PHQ-9 and GAD-7 | At intake and at the end of the episode | Completed today | PHQ-9 3 and GAD-7 4, from 7 and 8 |
| Self-management | Hepatitis B vaccine | Two doses at least four weeks apart | Completed today | Dose 2 given today; series complete |

## Goal progress

- Endoscopy within three days of the first visit, with cancer excluded by biopsy. Outcome by 1910-06-04: Endoscopy three days after the first visit; margin biopsies benign at two weeks. **S**
- No further bleeding and no emergency admission through the episode. Outcome by 1910-08-03: No further black stools or vomiting of blood; no admission. **S**
- Helicobacter pylori eradicated, confirmed by urea breath test. Outcome by 1910-08-03: Urea breath test negative seven weeks after therapy. **S**
- Gastric ulcer healed at repeat endoscopy. Outcome by 1910-08-03: Healed to a white scar at repeat endoscopy; scar biopsies sent. **S**
- Hemoglobin normal and ferritin above 50 ng/mL. Outcome by 1910-08-03: Hemoglobin 14.0 g/dL; ferritin 46 ng/mL, iron continuing. **S**

## Guideline basis

- ACG Clinical Guideline: Treatment of Helicobacter pylori Infection (2024), American College of Gastroenterology (Am J Gastroenterol 2024;119(9):1730-1753)
- Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report (2022), European Helicobacter and Microbiota Study Group (Gut 2022;71(9):1724-1762)
- Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition (2016 (published 2019)), Japanese Society for Helicobacter Research (Helicobacter 2019;24(4):e12597)
- Evidence-based clinical practice guidelines for peptic ulcer disease 2026 (2026), Japanese Society of Gastroenterology (J Gastroenterol 2026;61(10):1361-1381)
- ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding (2021), American College of Gastroenterology (Am J Gastroenterol 2021;116(5):899-917)
- Depression and Suicide Risk in Adults: Screening (2023), U.S. Preventive Services Task Force
- CMID: Clinical Monitoring Intelligence Database, anemia monograph (2026), Aether Forge
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Blood count, ferritin and A1c in three months. Upper endoscopy in one year. Scar biopsy result by phone. Call 119 for black, tarry stools, vomiting blood or fainting. **S**

